About Microbe Inotech Labs
Microbe Inotech Labs is a Healthcare company based in St. Louis (United States) founded in 1991, and was acquired by Pluton Biosciences in February 2020. It operates as a full-service microbiology testing and research are provided to multiple industries. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing. Its competitors include Evelo Biosciences, PathogenDX, AFYREN, Perfectus Biomed and Celsis and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Microbe Inotech Labs was established in 1991 in St. Louis, United States. Full-service microbiology laboratories are operated, with testing and research services extended to sectors such as food, agriculture, environment, pharmaceuticals, and industrial biotechnology. Operations focus on analytical support for industry needs, including microbial analysis and development projects, conducted from the primary location in the United States.
- Headquarters St. Louis, United States
- Stage Acquired
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website microbeinotech.com
- Social LinkedIn X
- Acquired by Pluton Biosciences (Feb 2020)
- Investors
- Acquired byPluton Biosciences
(Feb 2020)
Investors in Microbe Inotech Labs
Microbe Inotech Labs has secured backing from 1 investor. Prominent investors backing the company include Pluton Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Assay-based microbial research services are offered for industrial applications. | 2017 | plutonbio.com | St. Louis, United States |
Investor details for Microbe Inotech Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Microbe Inotech Labs
2 dated milestones of Microbe Inotech Labs across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Microbe Inotech Labs is founded.
- Exit Acquired by Pluton Biosciences.
Competitors of Microbe Inotech Labs
Microbe Inotech Labs has 10 listed competitors in our database, 9 of them funded. They include Evelo Biosciences, PathogenDX, AFYREN, Perfectus Biomed and Celsis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| pathogendx.com | 2014 | Tucson, United States | $11.58M | 31 | Provider of DNA-based pathogen testing kits | |
| afyren.com | 2012 | Paris, France | $25.59M | – | Analytical services are provided for microbiology, chemistry, and bioprocesses sectors. | |
| perfectusbiomed.com | 2012 | Daresbury, United Kingdom | $396,023 | 57 | Provides services for research-based approach for microbiological testing | |
| celsis.com | 1994 | Chicago, United States | $36.8M | – | Rapid microbial screening systems are manufactured for quality control testing. | |
| biopsin.com | 2018 | Singapore | $175,000 | – | Real-time microbial detection system is developed for product testing. | |
| mesosil.com | 2016 | Toronto, Canada | $1.6M | – | Antimicrobial materials are developed for infection prevention in medical devices. | |
| spore.bio | 2022 | Paris, France | $31.61M | – | Microbial detection technology is developed for life science industries. | |
| sourcemolecular.com | 2002 | Miami, United States | $1.62M | – | Technology for microbial source tracking is provided by Source Molecular. | |
| tepnelpharmaservices.com | 2013 | Wythenshawe, United Kingdom | – | 33 | Provider of analytical and quality testing services for drug development and diagnostics |
Detailed competitors of Microbe Inotech Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Microbe Inotech Labs
Websites that share an audience with Microbe Inotech Labs (microbeinotech.com).
Websites whose visitors overlap most with Microbe Inotech Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| titanbiotechltd.com | 89% | 14.6K | #1,498,243 | View details |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Microbe Inotech Labs (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Microbe Inotech Labs
Complete news archive for Microbe Inotech Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Microbe Inotech Labs
Microbe Inotech Labs was founded in 1991.
Microbe Inotech Labs is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Microbe Inotech Labs was established in 1991 in St. Louis, United States. Full-service microbiology laboratories are operated, with testing and research services extended to sectors such as food, agriculture, environment, pharmaceuticals, and industrial biotechnology. Operations focus on analytical support for industry needs, including microbial analysis and development projects, conducted from the primary location in the United States.
Microbe Inotech Labs's top competitors include PathogenDX, AFYREN and Perfectus Biomed.
Microbe Inotech Labs has 1 investor. Key investors include Pluton Biosciences.
Yes. Microbe Inotech Labs was acquired by Pluton Biosciences in February 2020.

